Md L. Rahman
Nagakute, 4801195, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.
Journal: Cell death & disease
Published: January 20, 2026
Characterization of targeted knock-in achieved via tandem paired nicking mediated by CRISPR/Cas9 nickases.
Journal: Methods (San Diego, Calif.)
Published: February 27, 2025
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma.
Journal: Cell death & disease
Published: February 11, 2025
New ZNHIT3 Variants Disrupting snoRNP Assembly Cause Prenatal PEHO Syndrome with Isolated Hydrops.
Journal: medRxiv : the preprint server for health sciences
Published: September 10, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.
Journal: Cell death discovery
Published: June 22, 2023
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Journal: Cell death discovery
Published: December 05, 2022
PDZ-binding kinase inhibitor OTS514 suppresses the proliferation of oral squamous carcinoma cells.
Journal: Oral diseases
Published: April 28, 2022
Flow cytometry-based quantification of targeted knock-in events in human cell lines using a GPI-anchor biosynthesis gene PIGP.
Journal: Bioscience reports
Published: September 17, 2021
Correction of a CD55 mutation to quantify the efficiency of targeted knock-in via flow cytometry.
Journal: Molecular biology reports
Published: September 06, 2021
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking.
Journal: Scientific reports
Published: May 19, 2021
Last Updated: 09/26/2026